Inventor
Chaohui Yang
Inventor
Suzhou, CN
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Bprimary
C07BGeneral methods of organic chemistry17%
C07DHeterocyclic compounds17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
A61KPreparations for medical, dental or toiletry purposes13%
C07CAcyclic or carbocyclic compounds9%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for4%
A23PShaping or working of foodstuffs, not fully covered by a single other subclass4%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation4%
B33YAdditive manufacturing, i.e. manufacturing of three-dimensional [3d] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3d printing, stereolithography or selective laser sintering4%
A21CMachines or equipment for making or processing doughs2%
PatentTitleYear
10,874,133Adjusting and control method for 3D printing precise shape forming of instant recuperation mashed potato202010,815,232Crystalline forms of viral-protein inhibitor drug VX-787, processes for preparation thereof and use thereof202010,798,964Method for improving moldability and 3D precision printing performance of high-fiber dough system by adding functional carbohydrate202010,508,087Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof201910,490,891Antenna adjustment method, antenna, and base station control center201910,463,873Non-invasive phototherapeutic system201910,351,536Crystalline forms of lesinurad and its sodium salt201910,323,035Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereof201910,233,144Crystalline form of AHU377, preparation method and use thereof20199,969,701Salts and co-crystals of lesinurad20189,957,240Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof20189,751,889'Crystalline form I of ibrutinib'2017Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2017–2019Patents assigned to SUZHOU PENGXU PHARMATECH CO LTD (5)· patent assignee history
2017–2018Patents assigned to CRYSTAL PHARMATECH INC (2)· patent assignee history
2017–2020Based in Suzhou, CN· patent location history
2018–2019Patents assigned to CRYSTAL PHARMATECH CO LTD (6)· patent assignee history
2019Patents assigned to CHEN MINHUA (1)· patent assignee history
2019Based in Jiangsu, CN· patent location history
2019Based in Xi'an, CN· patent location history
2020Patents assigned to UNIV JIANGNAN (2)· patent assignee history
2020Based in Wuxi, CN· patent location history
2020Based in Nanjing, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CRYSTAL PHARMATECH CO LTD | 6 | 2018–2019 |
| SUZHOU PENGXU PHARMATECH CO LTD | 5 | 2017–2019 |
| CRYSTAL PHARMATECH INC | 2 | 2017–2018 |
| UNIV JIANGNAN | 2 | 2020 |
| CHEN MINHUA | 1 | 2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Suzhou, CN | 6 | 2017–2020 |
| Jiangsu, CN | 2 | 2019 |
| Wuxi, CN | 1 | 2020 |
| Nanjing, CN | 1 | 2020 |
| Xi'an, CN | 1 | 2019 |